Your browser doesn't support javascript.
loading
Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.
Kisalu, Neville K; Idris, Azza H; Weidle, Connor; Flores-Garcia, Yevel; Flynn, Barbara J; Sack, Brandon K; Murphy, Sean; Schön, Arne; Freire, Ernesto; Francica, Joseph R; Miller, Alex B; Gregory, Jason; March, Sandra; Liao, Hua-Xin; Haynes, Barton F; Wiehe, Kevin; Trama, Ashley M; Saunders, Kevin O; Gladden, Morgan A; Monroe, Anthony; Bonsignori, Mattia; Kanekiyo, Masaru; Wheatley, Adam K; McDermott, Adrian B; Farney, S Katie; Chuang, Gwo-Yu; Zhang, Baoshan; Kc, Natasha; Chakravarty, Sumana; Kwong, Peter D; Sinnis, Photini; Bhatia, Sangeeta N; Kappe, Stefan H I; Sim, B Kim Lee; Hoffman, Stephen L; Zavala, Fidel; Pancera, Marie; Seder, Robert A.
Afiliação
  • Kisalu NK; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Idris AH; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Weidle C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Flores-Garcia Y; Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Flynn BJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Sack BK; Seattle Biomedical Research Institute, Seattle, Washington, USA.
  • Murphy S; Seattle Biomedical Research Institute, Seattle, Washington, USA.
  • Schön A; Department of Biology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Freire E; Department of Biology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Francica JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Miller AB; Division of Health Sciences and Technology, Institute for Medical Engineering and Science, and The Broad Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Gregory J; Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • March S; Division of Health Sciences and Technology, Institute for Medical Engineering and Science, and The Broad Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Liao HX; Duke Human Vaccine Institute, Durham, North Carolina, USA.
  • Haynes BF; College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Wiehe K; Duke Human Vaccine Institute, Durham, North Carolina, USA.
  • Trama AM; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Saunders KO; Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.
  • Gladden MA; Duke Human Vaccine Institute, Durham, North Carolina, USA.
  • Monroe A; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Bonsignori M; Duke Human Vaccine Institute, Durham, North Carolina, USA.
  • Kanekiyo M; Duke Human Vaccine Institute, Durham, North Carolina, USA.
  • Wheatley AK; Department of Surgery, Duke University School of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • McDermott AB; Duke Human Vaccine Institute, Durham, North Carolina, USA.
  • Farney SK; Duke Human Vaccine Institute, Durham, North Carolina, USA.
  • Chuang GY; Duke Human Vaccine Institute, Durham, North Carolina, USA.
  • Zhang B; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Kc N; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Chakravarty S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Kwong PD; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Sinnis P; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Bhatia SN; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Kappe SHI; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Sim BKL; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Hoffman SL; Sanaria Inc., Rockville, Maryland, USA.
  • Zavala F; Sanaria Inc., Rockville, Maryland, USA.
  • Pancera M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Seder RA; Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Nat Med ; 25(1): 188-189, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30552419
In the version of this article originally published, data were incorrectly ascribed to monoclonal antibody CIS34 because of a labeling error. The data were generated with monoclonal antibody CIS04. Full details can be found in the correction notice.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article